Proxy Statements (Def-14A)
NYSE
ALC
Alcon INCAlcon announced a definitive merger agreement to acquire STAAR Surgical for $28 per share in cash, valuing the company at approximately $1.5 billion.
Capital raise
Better than expected
Schedule 13G - Passive Investments
NYSE
ALC
Alcon INCSCHEDULE 13G/A: BlackRock Discloses 5.9% Passive Stake in Alcon Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.9% beneficial ownership stake in Alcon Inc.'s common stock as of March 31, 2025.